Investment
Features
FeesSafety
Academy
More
Pluang+

Compare The Travelers Companies Inc. Common Stock (TRV) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

The Travelers Companies Inc. Common StockTrade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

The Travelers Companies Inc. Common Stock vs State Street SPDR S&P Biotech ETF — how do they compare? The Travelers Companies Inc. Common Stock trades at $368.38 (market cap $77.23B), while State Street SPDR S&P Biotech ETF trades at $151.86 (market cap $10.11B). The key difference: The Travelers Companies Inc. Common Stock is far larger — about 7.6× State Street SPDR S&P Biotech ETF's market cap, and The Travelers Companies Inc. Common Stock pays a 1.35% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold The Travelers Companies Inc. Common Stock for 0 Days and State Street SPDR S&P Biotech ETF for 37 Days on average.

TRVXBI
Market Cap
$77.23B$10.11B
Volume
1,078,68212,903,266
Sector
FinancialsBroad Market / Factor
52-Week High
$397.22$169.55
52-Week Low
$261.57$104.99
Typical Hold Time
0 Days37 Days
Enterprise Value
$85.82B—
Dividend Yield
1.35%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

The Travelers Companies Inc. Common Stock

No Aura AI signal available yet.

State Street SPDR S&P Biotech ETF

XBI trades at $153.34, up 2.07% today, but faces bearish technical signals with 17 sell indicators versus 4 buys. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from recent M&A activity and positive clinical trial catalysts. Current price sits near resistance at $154, with support at $147.

Biotech sector optimism is growing with cancer vaccine breakthroughs and improved capital access, though XBI's 0.35% expense ratio is higher than broader healthcare ETFs. Key risks include sector volatility and regulatory uncertainty, while analyst consensus remains neutral with 100% hold rating.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TRV
100% Buy0% Sell
Avg holding period · 0 Days
XBI
100% Buy0% Sell
Avg holding period · 37 Days

About The Travelers Companies Inc. Common Stock

The Travelers Companies provides property and casualty insurance for individuals, businesses, and organizations. Its products include auto, home, and commercial coverage.

Read more on TRV →

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI →